2021 annual financial data
Gyre Therapeutics 2021 Operating margin
Direct answer
Operating margin was -1,140.99%.
Operating income was -83,726,000 CNY and net income was -87,933,000 CNY.
Operating cash flow was -83,755,000 CNY.
Get free Gyre Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,338,000 CNY
- Operating income
- -83,726,000 CNY
- Net income
- -87,933,000 CNY
- Operating cash flow
- -83,755,000 CNY